A genome-wide association study of high-sensitivity C-reactive protein in a large Korean population highlights its role in cholesterol metabolism

Kwangyeon Oh,Minju Yuk,Soyoun Yang,Jiyeong Youn,Qian Dong,Zhaoming Wang,Nan Song
DOI: https://doi.org/10.1101/2024.06.27.600933
2024-06-28
Abstract:High-sensitivity C-reactive protein (hsCRP) is a representative biomarker of systemic inflammation and is associated with numerous complex diseases. To explore the biological pathways and functions underlying chronic inflammation, we conducted a genome-wide association study (GWAS) and several post-GWAS analyses of the hsCRP levels. This study was performed on data from 71,019 Koreans and is one of the largest East Asian studies. Overall, 69 independent single nucleotide polymorphisms (SNPs) were identified, including 12 novel variants located within SHE, RP11-740C1.2, FCRL6, STEAP1B, AC002480.5, TOMM7, SPPL3, RP11-216P16.6, RP11-209K10.2, CTC-490E21.12, CYP2F2P, CBLC, and PVRL2. The implicated genes and pathways are primarily involved in cholesterol metabolism and the immune response. A phenome-wide association study was performed based on a polygenic risk score constructed using 69 hsCRP-associated SNPs. Notably, the alleles associated with higher hsCRP levels appeared to be associated with lower low-density lipoprotein cholesterol levels (P=1.69 x 10-33, beta= -1.47). Our findings provide evidence of a link between hsCRP and cholesterol as well as the clinical importance of hsCRP. Specifically, we suggest that genetically determined hsCRP levels may be useful for predicting the potential risk of cardiovascular or other diseases related to lipid metabolism.
Genomics
What problem does this paper attempt to address?